Trade ORKA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Oruka Therapeutics, Inc. (ORKA) is trading at US$104.99, down 2.03% today as of Nov 12, 16:00 EST. The company has a market capitalisation of US$7.11B. Over the past 52 weeks, ORKA has traded between US$25.23 and US$115.52. On Syfe you can trade ORKA with $0 commission and add it to your watchlist.
| Previous close | US$107.17 |
|---|---|
| Market cap | US$7.11B |
| 52-week range | US$25.23 – US$115.52 |
| Volume | 1.14M |
| Exchange | US |
Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Year: 2024
Oruka Therapeutics Insider Sold Shares Worth $805,889, According to a Recent SEC Filing
Oct 13, 8:37 PM · MT Newswires
Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says
Sep 24, 5:02 PM · MT Newswires
Update: Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001
Sep 23, 6:28 PM · MT Newswires
Oruka Therapeutics, Inc. (ORKA) stock is trading at US$104.99, -2.03% from the previous close of US$107.17.
The market cap for Oruka Therapeutics, Inc. (ORKA) stock is approximately US$7.11B.
The 52-week high for Oruka Therapeutics, Inc. (ORKA) stock is US$115.52.
The 52-week low for Oruka Therapeutics, Inc. (ORKA) stock is US$25.23.
Oruka Therapeutics, Inc. (ORKA) does not currently pay a dividend.
Stay on top of ORKA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
